Literature DB >> 20578016

Morphological features and clinical feasibility of thoracic duct: detection with nonenhanced magnetic resonance imaging at 3.0 T.

De-xin Yu1, Xiang-xing Ma, Xiao-ming Zhang, Qing Wang, Chuan-fu Li.   

Abstract

PURPOSE: To evaluate the detection of the thoracic duct using nonenhanced magnetic resonance imaging (MRI) and to determine the influence of some related disorders on the lymphatic duct.
MATERIALS AND METHODS: Highly fluid-sensitive sequence and fat-suppressed T2-weighted imaging (FS-T2WI) were performed in a total of 139 cases. The axial and coronal images were used to locate the thoracic duct and the measurement and evaluation of its dimensions were performed using a 3D maximum intensity projection (MIP) reconstruction image. The differences in the dimensions among control, portal hypertension, and common bile duct obstruction groups were compared using one-way analysis of variance.
RESULTS: The cisterna chyli was shown in 91% of cases on FS-T2WI, while the thoracic duct appeared in 70% of the MIP images. The common configuration of the cisterna chyli was tubular or saccular in 73%. Eighty thoracic ducts had a slight turn declining to the left at the level of T8-10. There was a significant difference in the transverse diameter of the thoracic duct between the portal hypertension group and other groups (F = 5.638, P = 0.005).
CONCLUSION: Nonenhanced MRI is feasible for locating and depicting the morphological features of the thoracic duct. Portal hypertension may influence the dimension of the thoracic duct. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20578016     DOI: 10.1002/jmri.22128

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  8 in total

Review 1.  Proteolysis and Oxidation of Therapeutic Proteins After Intradermal or Subcutaneous Administration.

Authors:  Ninad Varkhede; Rupesh Bommana; Christian Schöneich; M Laird Forrest
Journal:  J Pharm Sci       Date:  2019-08-10       Impact factor: 3.534

2.  Localization of thoracic duct using heavily T2W MRI for intractable post-esophagectomy chylothorax-a case report.

Authors:  Yi-Chien Chang; Yi-Ting Yen; Ming-Chung Chang; Yau-Lin Tseng
Journal:  J Thorac Dis       Date:  2017-02       Impact factor: 2.895

3.  Morphological changes of the thoracic duct and accessory lymphatic channels in patients with chylothorax: detection with unenhanced magnetic resonance imaging.

Authors:  De-Xin Yu; Xiang-Xing Ma; Qing Wang; Yang Zhang; Chuan-Fu Li
Journal:  Eur Radiol       Date:  2012-09-14       Impact factor: 5.315

4.  Dynamic contrast-enhanced magnetic resonance lymphangiography in pediatric patients with central lymphatic system disorders.

Authors:  Veronica Bordonaro; Paolo Ciancarella; Paolo Ciliberti; Davide Curione; Carmela Napolitano; Teresa Pia Santangelo; Gian Luigi Natali; Massimo Rollo; Paolo Guccione; Luciano Pasquini; Aurelio Secinaro
Journal:  Radiol Med       Date:  2021-01-04       Impact factor: 3.469

Review 5.  MRI of the Central Lymphatic System: Indications, Imaging Technique, and Pre-Procedural Planning.

Authors:  Vishwan Pamarthi; Waleska M Pabon-Ramos; Vincent Marnell; Lynne M Hurwitz
Journal:  Top Magn Reson Imaging       Date:  2017-08

Review 6.  Management of Chyle Leak after Head and Neck Surgery: Review of Current Treatment Strategies.

Authors:  Sean W Delaney; Haoran Shi; Alireza Shokrani; Uttam K Sinha
Journal:  Int J Otolaryngol       Date:  2017-01-19

7.  Changes of thoracic duct flow and morphology in an animal model of elevated central venous pressure.

Authors:  Xiao Lu; Mengjun Wang; Ling Han; Joshua Krieger; Jillian Ivers; Sean Chambers; Max Itkin; Daniel Burkhoff; Ghassan S Kassab
Journal:  Front Physiol       Date:  2022-08-08       Impact factor: 4.755

8.  Morphology of the distal thoracic duct and the right lymphatic duct in different head and neck pathologies: an imaging based study.

Authors:  Ferdinand J Kammerer; Benedikt Schlude; Michael A Kuefner; Philipp Schlechtweg; Matthias Hammon; Michael Uder; Siegfried A Schwab
Journal:  Head Face Med       Date:  2016-03-31       Impact factor: 2.151

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.